Desq Long
Sign in

Company

REGENXBIO Inc.

RGNX · CIK 0001590877

SEC FORM 4
$45,686.64

REGENXBIO Inc. (RGNX)

Disposition (code F) of 4,902 shares at $9.32 per share.

Reporting Person Chan Mitchell · Officer Title Chief Financial Officer · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001789335-26-000008 · filed 2026-09-03 · View filing →

SEC FORM 4
$2,180.88

REGENXBIO Inc. (RGNX)

Disposition (code F) of 234 shares at $9.32 per share.

Reporting Person Malzahn Craig · Officer Title Chief Technology Officer · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0002062007-26-000005 · filed 2026-09-03 · View filing →

SEC FORM 4
$499,675.89

REGENXBIO Inc. (RGNX)

Purchase of 53,407 shares at $9.356 per share.

Reporting Person Ciongoli Gregory Austin · Transaction Code P

Traded Aug 27, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0002023732-26-000008 · filed 2026-08-27 · View filing →

SEC FORM 4
$449,705.56

REGENXBIO Inc. (RGNX)

Purchase of 49,196 shares at $9.1411 per share.

Reporting Person Ciongoli Gregory Austin · Transaction Code P

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0002023732-26-000008 · filed 2026-08-27 · View filing →

SEC FORM 4
$0.00

REGENXBIO Inc. (RGNX)

Acquisition (code A) of 15,432 shares at $0.00 per share.

Reporting Person Ciongoli Gregory Austin · Transaction Code A

Traded Aug 25, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0002023732-26-000008 · filed 2026-08-27 · View filing →